Location
Date & Time
1:00pm CST - 2:30pm CST
About This Event
Wednesday, December 17, 2025 — 1:00 PM CST | 11:00 AM PST
Join Dr. Phillip “Randy” Torralva, MD, board-certified anesthesiologist, addiction medicine specialist, and CEO of TMT-Rx, Inc., for a compelling deep dive into one of the most alarming new threats in the opioid crisis: Nitazenes.
These ultra-potent synthetic opioids—estimated to be 40–50 times stronger than fentanyl—are emerging across the nation, driving a deadly new phase of overdose fatalities and legal complexity. With just two grains capable of producing lethal effects, Nitazenes present unprecedented challenges for law enforcement, forensic science, and the courts.
Dr. Torralva, whose NIH-supported research is conducted in collaboration with the DEA, will unpack the science and policy implications behind this new wave, covering:
-
The evolving pharmacology of fentanyl and its analogues.
-
Why Nitazenes are even more dangerous—unregulated precursors, rapid synthesis, and extreme lethality.
-
The limits of naloxone in reversing Nitazene overdoses.
-
New frontiers in reversal-agent research and emergency response.
Earn 1.5 hours of CLE credit while expanding your understanding of this critical intersection of law, science, and public safety.
This is your opportunity to hear directly from one of the nation’s leading researchers redefining how the justice system confronts synthetic opioid threats.
Hosted by the Therapeutic Justice Foundation
Live on Zoom — Wednesday, December 17 at 1:00pm CST
About This Event
Wednesday, December 17, 2025 — 1:00 PM CST | 11:00 AM PST
Join Dr. Phillip “Randy” Torralva, MD, board-certified anesthesiologist, addiction medicine specialist, and CEO of TMT-Rx, Inc., for a compelling deep dive into one of the most alarming new threats in the opioid crisis: Nitazenes.
These ultra-potent synthetic opioids—estimated to be 40–50 times stronger than fentanyl—are emerging across the nation, driving a deadly new phase of overdose fatalities and legal complexity. With just two grains capable of producing lethal effects, Nitazenes present unprecedented challenges for law enforcement, forensic science, and the courts.
Dr. Torralva, whose NIH-supported research is conducted in collaboration with the DEA, will unpack the science and policy implications behind this new wave, covering:
-
The evolving pharmacology of fentanyl and its analogues.
-
Why Nitazenes are even more dangerous—unregulated precursors, rapid synthesis, and extreme lethality.
-
The limits of naloxone in reversing Nitazene overdoses.
-
New frontiers in reversal-agent research and emergency response.
Earn 1.5 hours of CLE credit while expanding your understanding of this critical intersection of law, science, and public safety.
This is your opportunity to hear directly from one of the nation’s leading researchers redefining how the justice system confronts synthetic opioid threats.
Hosted by the Therapeutic Justice Foundation
Live on Zoom — Wednesday, December 17 at 1:00pm CST
Location
Date & Time
1:00pm CST - 2:30pm CST